Brian M Slomovitz

No ORCID on file · 6 papers in corpus · active 2002-2026

Study types

  • article 3
  • case-report 1
  • other 1
  • review 1

Condition tags

  • endometriosis 5
  • endometrioma 1
article 2026
Corrigendum to ‘Endometriosis and ovarian cancer risk’ [Gynecologic Oncology 209C (2026) 88–98]
·doi:10.1016/j.ygyno.2026.05.029
review 2026
Endometriosis and ovarian cancer risk
Gynecologic oncology ·doi:10.1016/j.ygyno.2026.05.004

OBJECTIVE: To critically evaluate the evidence linking endometriosis to ovarian cancer, with particular focus on endometrioid and clear cell histologic subtypes, and to inform risk stratification and patient counseling. METHODS: A systemat…

article 2024
TP005/#1564  Gog-3069: phase 2 study of alpelisib and fulvestrant for PIK3CA-mutated estrogen receptor-positive endometrioid endometrial cancers
·doi:10.1136/ijgc-2024-igcs.607
article 2019
Clear cell carcinoma arising from abdominal wall endometrioma after cesarean section
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1136/ijgc-2019-000808
other 2015
Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma
Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·doi:10.1200/JCO.2014.58.3401

PURPOSE: The phosphoinositol-3 kinase (PI3K) pathway is frequently dysregulated in endometrial cancer (EC). Hormonal manipulation leads to response in some patients with EC, but resistance derived from PI3K pathway activation has been docum…

case-report 2002
Serous adenocarcinoma of the inguinal region arising from endometriosis followed by a successful pregnancy
Gynecologic oncology ·doi:10.1006/gyno.2002.6790

BACKGROUND: Inguinal serous carcinoma arising from endometriosis is an unusual cancer. It is uncertain how patients with these tumors should be managed, especially those patients who desire future fertility. CASE: We present a 34-year-old …